Ametek (AME) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Ametek (AME) reported revenue of $1.89 billion, up 10.8% over the same period last year. EPS came in at $1.89, compared to $1.66 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.82 billion, representing a surprise of +4.16%. The company delivered an EPS surprise of +7.39%, with the consensus EPS estimate being $1.76.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Ametek performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- Electronic Instruments: $1.25 billion compared to the $1.21 billion average estimate based on five analysts. The reported number represents a change of +9.9% year over year.Net Sales- Electro mechanical: $646.31 million compared to the $604.65 million average estimate based on five analysts. The reported number represents a change of +12.6% year over year.Operating Income- Electronic Instruments: $352.44 million compared to the $346.7 million average estimate based on five analysts.Operating Income- Corporate administrative expenses: $-27.93 million versus $-27.1 million estimated by five analysts on average.Operating Income- Electromechanical: $163.88 million versus $140.16 million estimated by five analysts on average.View all Key Company Metrics for Ametek here>>>Shares of Ametek have returned -1.7% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AMETEK, Inc. (AME): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks